- Home
- RVSB vs MCRB Comparison
RVSB vs MCRB Comparison
Compare RVSB & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- MCRB
- Stock Information
- Founded
- RVSB 1923
- MCRB 2010
- Country
- RVSB United States
- MCRB United States
- Employees
- RVSB N/A
- MCRB N/A
- Industry
- RVSB Savings Institutions
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- MCRB Health Care
- Exchange
- RVSB Nasdaq
- MCRB Nasdaq
- Market Cap
- RVSB 122.2M
- MCRB 141.9M
- IPO Year
- RVSB 1993
- MCRB 2015
- Fundamental
- Price
- RVSB $5.14
- MCRB $0.80
- Analyst Decision
- RVSB
- MCRB Buy
- Analyst Count
- RVSB 0
- MCRB 4
- Target Price
- RVSB N/A
- MCRB $5.63
- AVG Volume (30 Days)
- RVSB 34.8K
- MCRB 844.5K
- Earning Date
- RVSB 01-30-2025
- MCRB 03-04-2025
- Dividend Yield
- RVSB 1.54%
- MCRB N/A
- EPS Growth
- RVSB N/A
- MCRB N/A
- EPS
- RVSB 0.04
- MCRB N/A
- Revenue
- RVSB $46,646,000.00
- MCRB $126,325,000.00
- Revenue This Year
- RVSB N/A
- MCRB N/A
- Revenue Next Year
- RVSB $13.88
- MCRB N/A
- P/E Ratio
- RVSB $139.08
- MCRB N/A
- Revenue Growth
- RVSB N/A
- MCRB 12856.41
- 52 Week Low
- RVSB $3.30
- MCRB $0.54
- 52 Week High
- RVSB $5.89
- MCRB $1.53
- Technical
- Relative Strength Index (RSI)
- RVSB 20.43
- MCRB 46.38
- Support Level
- RVSB $5.30
- MCRB $0.81
- Resistance Level
- RVSB $5.48
- MCRB $0.84
- Average True Range (ATR)
- RVSB 0.10
- MCRB 0.04
- MACD
- RVSB -0.04
- MCRB 0.00
- Stochastic Oscillator
- RVSB 0.00
- MCRB 45.58
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.